Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Update Il y a 4 ans
Reference: NCT00728585

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

RATIONALE: Palifermin may help relieve or prevent oral mucositis caused by chemotherapy and radiation therapy in young patients undergoing stem cell transplant. PURPOSE: This randomized phase II trial is studying palifermin to see how well it works compared with a placebo in preventing oral mucositis caused by chemotherapy and/or radiation therapy in young patients undergoing stem cell transplant.


Inclusion criteria

  • Breast Cancer,Graft-versus-host disease,Kidney Cancer,leukemia,LYMPHOMA,mucositis,Multiple myeloma,Plasma Cell Neoplasm,Myelodysplastic syndromes,Neuroblastoma,Ovarian Cancer,Sarcoma,Testicular Germ Cell Tumor

Links